Drug licenses: a new model for pharmaceutical pricing

Health Affairs
Dana P GoldmanEric Sun

Abstract

High drug prices are a major barrier to patients' access to drugs and compliance with treatment. Yet low drug prices are often argued to provide inadequate incentives for innovation. We propose a drug-licensing model for health care, which has the promise of increasing drug use without altering patients' out-of-pocket spending, health plans' costs, or drug companies' profits. In such a model, people would purchase annual drug licenses that would guarantee unfettered access to a clinically optimal number of prescriptions over the course of a year. Using the example of statins, we illustrate how such a model could be implemented.

References

May 8, 1986·The New England Journal of Medicine·N LurieR H Brook
Mar 10, 2001·JAMA : the Journal of the American Medical Association·R TamblynL Mallet
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Geoffrey F JoyceDana P Goldman
Mar 6, 2003·Medical Care·Thomas S RectorBharati S Manda
May 20, 2004·JAMA : the Journal of the American Medical Association·Dana P GoldmanSteven M Teutsch
Aug 26, 2004·JAMA : the Journal of the American Medical Association·Chien-Wen TsengCarol M Mangione

❮ Previous
Next ❯

Citations

May 21, 2011·The Journal of Economic Perspectives : a Journal of the American Economic Association·Katherine Baicker, Dana Goldman
Oct 31, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joel W HayLizheng Shi
May 10, 2018·Diabetes Care·William T CefaluUNKNOWN Insulin Access and Affordability Working Group
Oct 5, 2018·Tropical Medicine & International Health : TM & IH·Farimah RahimiFarzad Peiravian
Feb 9, 2018·Pharmaceutical Research·Szymon JarosławskiClaude Dussart
Dec 29, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Michael T Mueller, Alexander Frenzel
Nov 28, 2018·Journal of Market Access & Health Policy·Szymon Jarosławski, Mondher Toumi
Nov 14, 2020·International Journal of Environmental Research and Public Health·Rick A VremanWim G Goettsch
Mar 17, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Jakub P HlávkaDarius N Lakdawalla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Positively Aware : the Monthly Journal of the Test Positive Aware Network
Enid Vázquez
Health Affairs
Richard A Epstein
© 2021 Meta ULC. All rights reserved